Cubist Systematic Strategies, LLC Blueprint Medicines Corp Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 6,700 shares of BPMC stock, worth $606,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,700

Previous 4,901 36.71%

Holding current value

$606,082

Previous $528,000 17.23%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $417,467 - $533,130	4,901 New	4,901 $528,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $977,429 - $1.52 Million	-19,576 Reduced 41.11%	28,037 $1.85 Million
Q2 2022 Aug 15, 2022	BUY	$45.23 - $70.15 $731,323 - $1.13 Million	16,169 Added 51.42%	47,613 $2.41 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $1.23 Million - $2.5 Million	22,745 Added 261.47%	31,444 $2.01 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $761,163 - $936,735	8,076 Added 1296.31%	8,699 $932,000
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $2.95 Million - $3.99 Million	-36,404 Reduced 98.32%	623 $64,000
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $1.92 Million - $2.35 Million	23,251 Added 168.78%	37,027 $3.26 Million
Q1 2021 May 17, 2021	SELL	$90.71 - $108.28 $1.94 Million - $2.32 Million	-21,402 Reduced 60.84%	13,776 $1.34 Million
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $2.92 Million - $3.95 Million	31,721 Added 917.59%	35,178 $3.95 Million
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $13,223 - $18,447	-199 Reduced 5.44%	3,457 $320,000
Q2 2020 Aug 14, 2020	SELL	$57.09 - $79.27 $713,282 - $990,399	-12,494 Reduced 77.36%	3,656 $285,000
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $173,292 - $296,156	3,602 Added 28.71%	16,150 $944,000
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $169,494 - $209,778	2,540 Added 25.38%	12,548 $1.01 Million
Q3 2019 Nov 14, 2019	BUY	$72.9 - $101.41 $729,583 - $1.01 Million	10,008 New	10,008 $735,000
Q2 2019 Aug 14, 2019	SELL	$73.54 - $97.8 $530,370 - $705,333	-7,212 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $351,224 - $624,559	7,212 New	7,212 $577,000
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $160,406 - $261,395	-3,520 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$58.91 - $78.32 $207,363 - $275,686	3,520 New	3,520 $275,000
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $12,192 - $20,236	-200 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$73.28 - $102.95 $71,228 - $100,067	-972 Reduced 82.94%	200 $18,000
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $70,836 - $99,448	1,126 Added 2447.83%	1,172 $88,000
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $1,949 - $3,204	46	46 $3,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Blueprint Medicines Corp Transaction History